(Reuters) – A panel of expert advisers to the U.S. Food and Drug Administration voted on Thursday to recommend booster shots of Moderna Inc’s COVID-19 vaccine for Americans aged 65 and older and those at high risk of severe illness.
(Reporting by Manas Mishra in Bengaluru; Editing by Leslie Adler)
